Astera Labs, Inc. ALAB
364.62
4.11
1.14%
as of 25 Sep
- Market cap
- $63.7B
- P/E
- 168×
Follow ALAB
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
164.54 | 126.99 | 68.93 | 222.59 |
P/S ratio |
45.34 | 32.47 | 18.68 | 69.27 | |
P/FCF ratio |
142.89 | 98.25 | 54.58 | 300.94 | |
P/Operating CF |
419.39 | 290.60 | 250.83 | 949.63 | |
P/B ratio |
25.78 | 20.30 | 12.52 | 48.25 | |
Price to Tangible BV |
25.78 | 20.59 | 13.31 | 50.95 | |
EV/Sales |
43.77 | 31.08 | 17.50 | 68.23 | |
EV/EBITDA |
310.95 | 153.75 | 77.28 | 293.13 | |
EV/Operating CF |
120.00 | 82.98 | 45.71 | 244.28 | |
EV/FCF |
137.94 | 94.03 | 51.13 | 296.41 | |
Quick Ratio |
11.66 | 9.56 | 10.55 | 8.80 | |
Current Ratio |
12.78 | 10.24 | 11.30 | 10.05 | |
Net Debt/EBITDA |
(20.59) | (17.44) | (18.41) | (13.59) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.61 | 0.66 | 0.72 | 0.75 | |
Operating CF/Net income |
0.86 | 2.12 | 0.93 | 0.57 | |
Capex/Depreciation |
38.06 | (15.68) | (3.02) | (6.94) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
34.23% | 34.66% | 40.74% | 34.63% | |
Selling, General and Administrative Expense of Revenue |
17.99% | 16.16% | 15.46% | 15.91% | |
Intangible Assets out of Total Assets |
0.00 | 0.01 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
17.67% | 15.29% | 15.86% | 16.31% | |
Graham Net Nets |
0.04 | 0.04 | 0.07 | 0.02 | |
Graham Number |
14.26 | 15.54 | 17.69 | 22.11 | |
Earnings Yield |
0.61% | 0.79% | 1.45% | 0.45% | |
Free Cash Flow Yield |
0.70% | 1.02% | 1.83% | 0.33% | |
Revenue per Share |
1.38 | 1.63 | 1.81 | 2.28 | |
Operating CF per Share |
0.47 | 0.57 | 0.44 | 0.51 | |
Capex per Share |
(0.07) | (0.11) | (0.04) | (0.12) | |
Free Cash Flow per Share |
0.39 | 0.46 | 0.39 | 0.39 | |
Cash per Share |
6.78 | 7.14 | 6.94 | 7.27 | |
Shareholders Equity per Share |
7.60 | 8.19 | 8.75 | 10.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.60 | 8.19 | 8.75 | 10.01 | |
Free Cash Flow |
65.88 | 76.58 | 67.01 | 67.21 | |
Working Capital |
1,189.20 | 1,228.99 | 1,287.89 | 1,487.59 | |
Capital Expenditures |
(12.29) | (18.69) | (7.59) | (20.47) | |
Net Current Asset Value |
1,160.71 | 1,193.84 | 1,247.67 | 1,446.10 | |
EV/EBIT |
296.87 | 152.78 | 78.26 | 299.91 | |
Capex to Sales |
0.05 | 0.07 | 0.02 | 0.05 | |
Net Profit Margin |
39.52% | 16.62% | 26.04% | 39.01% | |
Price to Operating Income |
307.52 | 159.63 | 83.54 | 304.49 | |
| Other line items | |||||
Average Receivables |
34.14 | 61.01 | 102.29 | 108.39 | |
Average Payables |
22.18 | 34.64 | 42.67 | 42.75 | |
Average Inventory |
38.04 | 51.10 | 55.61 | 86.19 | |
Average Assets |
1,192.12 | 1,293.17 | 1,390.45 | 1,601.45 | |
Average Common Equity |
1,080.67 | 1,164.22 | 1,267.76 | 1,430.71 |
Columns are period end dates